Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q3 FY21 results · Oct–Dec 2020
Advanced Enzyme Technologies reported revenue from operations of ₹137.74 crore (up 23.0% from Q3 FY20) and net profit of ₹44.30 crore (up 28.2% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a consolidated basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 137.74 | 111.94 | +23.0% | 120.39 | +14.4% |
| Other income | 1.35 | 1.21 | +11.9% | 0.58 | +131.6% |
| Total income | 139.09 | 113.15 | +22.9% | 120.97 | +15.0% |
| Profit before tax | 60.91 | 46.89 | +29.9% | 51.91 | +17.3% |
| Net profit for the period | 44.30 | 34.56 | +28.2% | 38.56 | +14.9% |
| Attributable to shareholders of the company | 43.09 | 33.60 | +28.2% | — | — |
| EPS, basic (₹) | 3.86 | 3.01 | +28.2% | 3.33 | +15.9% |
| Net margin (%) | 32.2 | 30.9 | 32.0 |
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 79.14 | 61.51 | +28.7% | 72.31 | +9.4% |
| Other income | 1.77 | 4.97 | −64.3% | 1.74 | +2.2% |
| Total income | 80.92 | 66.48 | +21.7% | 74.05 | +9.3% |
| Profit before tax | 26.42 | 21.80 | +21.2% | 28.21 | −6.3% |
| Net profit for the period | 20.32 | 17.53 | +15.9% | 20.13 | +0.9% |
| EPS, basic (₹) | 1.82 | 1.57 | +15.9% | 1.80 | +1.1% |
| Net margin (%) | 25.7 | 28.5 | 27.8 |
Consolidated
- Filed with BSE
- 12 Feb 2021, 16:29 IST
- Board meeting
- 12 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Feb 2021, 16:29 IST
- Board meeting
- 12 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE